Vanda Pharmaceuticals Inc. (VNDA)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
As of 02:46PM EDT. Market open.
| Previous Close | 4.0600 |
| Open | 4.0200 |
| Bid | 3.9900 x 100 |
| Ask | 4.0900 x 100 |
| Day's Range | 3.9850 - 4.0800 |
| 52 Week Range | 3.3000 - 7.0000 |
| Volume | |
| Avg. Volume | 1,882,125 |
| Market Cap | 232.739M |
| Beta (5Y Monthly) | 0.78 |
| PE Ratio (TTM) | 101.13 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Vanda Pharmaceuticals (VNDA) Declines More Than Market: Some Information for Investors
Vanda Pharmaceuticals (VNDA) concluded the recent trading session at $4.06, signifying a -1.46% move from its prior day's close.
- Zacks
Vanda Pharmaceuticals (VNDA) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Vanda Pharmaceuticals (VNDA) closed at $4.28 in the latest trading session, marking a -1.83% move from the prior day.
- Zacks
AstraZeneca's (AZN) Enhertu Gets FDA Nod for Solid Tumors
FDA approves AstraZeneca (AZN) and partner Daiichi Sankyo's Enhertu for HER2-expressing metastatic cancers based on data from three phase II studies.
© 2024 Yahoo. All rights reserved.